# FDA Inspection 1057142 - Biomat USA Inc - May 29, 2018

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/fb89d3cc-a810-42ef-a84c-71dfe08eb2ac
Source feed: FDA_Inspections

> FDA Inspection 1057142 for Biomat USA Inc on May 29, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1057142
- Company Name: Biomat USA Inc
- Inspection Date: 2018-05-29
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1196124 - 2023-01-13](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/1165d759-62df-4643-9551-0a0e56800e86)
- [FDA Inspection 1196124 - 2023-01-13](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/e06b21e9-562b-4ddc-970b-03802c8960c8)
- [FDA Inspection 969080 - 2016-04-27](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/5eb5f302-444d-4243-9b98-45bc7b2f621a)
- [FDA Inspection 867478 - 2014-02-24](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/a8e292f7-9831-4848-826a-bcfb3ee8f656)
- [FDA Inspection 753878 - 2011-11-18](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/9690f077-e246-4b2e-871f-ebb4268c05f4)

Company: https://www.keypedia.com/companies/biomat-usa-inc/bb09c108-6ef2-4a53-9a44-09d9196bc91c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d